Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022)

ALK-Abelló

Status: Completed

Conditions: Perennial Allergic Rhinitis; Seasonal Allergic Rhinitis

Study type: Observational

Funder types: Industry

Identifiers

NCT01549340

7243-022

Details and patient eligibility

About

The purpose of this study is to determine the proportion of participants that initiate allergen immunotherapy (AIT) upon the recommendation of their physician and the proportion of participants that persist with their AIT throughout the recommended course.

Enrollment: 8,790 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of AR with or without allergic conjunctivitis (AC)
• Documented provider-to-patient or parent discussion of AIT as a treatment option

Exclusion criteria

• Participants receiving AIT as an AR treatment without documented provider-to-patient or parent discussion of AIT as a treatment option
• Participants receiving immunotherapy for insect sensitivities only
• AIT started before 2005

Trial design

8,790 participants in 1 patient group

Participants with Allergic Rhinitis (AR)

Description:

Patients in a private allergy practice who were diagnosed with AR, with or without asthma, and advised to consider AIT between January 2005 and June 2011 and whose medical records were retrospectively reviewed.